Christopher Murphy
Direttore Finanziario/CFO presso THIRD HARMONIC BIO, INC.
Profilo
Christopher M.
Murphy is currently the Chief Financial & Business Officer at Third Harmonic Bio, Inc. Prior to this, he worked as the Group Vice President-Commercial Operations at Horizon Therapeutics Plc.
He completed his undergraduate degree at the University of Notre Dame.
Posizioni attive di Christopher Murphy
| Società | Posizione | Inizio |
|---|---|---|
| THIRD HARMONIC BIO, INC. | Direttore Finanziario/CFO | 04/01/2024 |
Precedenti posizioni note di Christopher Murphy
| Società | Posizione | Fine |
|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - |
Formazione di Christopher Murphy
| University of Notre Dame | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| THIRD HARMONIC BIO, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
- Borsa valori
- Insiders
- Christopher Murphy
